Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.12%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.00%
#5 RedStone RedStone +28.08%
#6 Humanity Humanity +25.92%
#7 Codatta Codatta +22.12%
#8 Walrus Walrus +20.05%
#9 Enso Enso +18.97%
#10 Tutorial Tutorial +17.31%
Coin of the day
EXOD EXOD
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Carmat S.A. Carmat S.A.

Carmat S.A.

ALCAR
Pozycja w akcjach #36478
Carmat SA specializes in engineering and creating a full artificial heart,... Carmat SA specializes in engineering and creating a full artificial heart, specifically designed for individuals worldwide who are afflicted with severe, late-stage biventricular heart failure. The company commenced operations in 2008 and is based in Vélizy-Villacoublay, France.
Cena akcji
$0.11526505
Ostatnia synchronizacja: 2025-10-20
Kapitalizacja rynkowa
$2.63M
Zmiana (1 dzień)
-0.15%
Zmiana (1 rok)
-79.05%
Kraj
FR
Handel Carmat S.A. (ALCAR)

Kategoria

Healthcare
Historia stopy dywidendy dla Carmat S.A. (ALCAR)
Stopa dywidendy (TTM) dla Carmat S.A. (symbol akcji: ALCAR) na dzień 2023-12-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Carmat S.A. (ALCAR) od 2009 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
2.23%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
1.03%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
3.69%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US